Browsing Tag
Klotho Neurosciences
4 posts
The unexpected mining pivot that could redefine Klotho Neurosciences, Inc.
Klotho Neurosciences acquires Greenland Mines and secures control of the $68B Skaergaard deposit. Discover why this mining pivot could reshape the company.
Klotho Neurosciences expands beyond the anti-aging gene with Turn Biotechnologies acquisition plan
Klotho Neurosciences moves to buy Turn Bio’s ERA and eTurna assets plus a $300M Korea pharma deal. Explore how this could reshape its longevity pipeline.
Klotho Neurosciences teams up with AAVnerGene to scale gene therapies for Alzheimer’s, ALS, and longevity
Klotho Neurosciences partners with AAVnerGene to accelerate AAV-based gene therapies for Alzheimer’s, ALS, and aging; aims for lower cost and higher precision.
Klotho Neurosciences begins manufacturing KLTO-202 gene therapy to advance clinical trials in ALS
Klotho Neurosciences begins KLTO-202 manufacturing to prepare for ALS clinical trials, with a gene therapy targeting neuroprotection in spinal neurons.